Literature DB >> 27974906

Gene Transfer for Pain: A tool to cope with the intractable, or an unethical endurance-enhancing technology?

S Camporesi1, M J McNamee2.   

Abstract

Entities:  

Year:  2012        PMID: 27974906      PMCID: PMC5152710          DOI: 10.1186/1746-5354-8-1-20

Source DB:  PubMed          Journal:  Genom Soc Policy        ISSN: 1746-5354


× No keyword cloud information.

Note

please consult PDF for full article
  18 in total

1.  Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.

Authors:  Sam Horng; Christine Grady
Journal:  IRB       Date:  2003 Jan-Feb

Review 2.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

3.  Fluctuating baseline pain implicated in failure of clinical trials.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

4.  Hypoxic air machines. Commentary.

Authors:  T Tännsjö
Journal:  J Med Ethics       Date:  2005-02       Impact factor: 2.903

5.  Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trials.

Authors:  Jonathan Kimmelman; Aaron Levenstadt
Journal:  Hum Gene Ther       Date:  2005-04       Impact factor: 5.695

Review 6.  VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond.

Authors:  M Giacca; S Zacchigna
Journal:  Gene Ther       Date:  2012-03-01       Impact factor: 5.250

Review 7.  Therapeutic angiogenesis: theoretic problems using vascular endothelial growth factor.

Authors:  I Baumgartner
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

8.  10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb.

Authors:  K Muona; K Mäkinen; M Hedman; H Manninen; S Ylä-Herttuala
Journal:  Gene Ther       Date:  2011-07-21       Impact factor: 5.250

9.  Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes.

Authors:  Katrina Karkazis; Rebecca Jordan-Young; Georgiann Davis; Silvia Camporesi
Journal:  Am J Bioeth       Date:  2012       Impact factor: 11.229

Review 10.  Gene therapy in the treatment of peripheral arterial disease.

Authors:  N A Mughal; D A Russell; S Ponnambalam; S Homer-Vanniasinkam
Journal:  Br J Surg       Date:  2011-11-08       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.